Inactive Instrument

Hydromer, Inc. Stock Other OTC

Equities

HYDI

US4490011065

Specialty Chemicals

Sales 2017 5.45M Sales 2018 5.63M Capitalization 2.01M
Net income 2017 -1M Net income 2018 - EV / Sales 2017 0.95 x
Net Debt 2017 2.08M Net Debt 2018 2.2M EV / Sales 2018 0.75 x
P/E ratio 2017
-2.43 x
P/E ratio 2018
33 x
Employees -
Yield 2017 *
-
Yield 2018
-
Free-Float 43.27%
More Fundamentals * Assessed data
Dynamic Chart
Hydromer, Inc. Announces Sales Results for the Fiscal Year Ended December 31, 2023 CI
Hydromer, Inc. Revises Fiscal Year from June 30 to December 31 CI
Hydromer, Inc. Announces the Relaunch of its Legendary SeaSlide?? Hydrophilic Watercraft Coating CI
Hydromer, Inc. Announces Board Changes CI
Hydromer, Inc Appoints Michael E. Torti as Chief Executive Officer CI
Hydromer, Inc. Removes Peter Von Dyck as CEO CI
Hydromer, Inc. Appoints Cam Cruickshank as Board of Directors CI
Hydromer, Inc. Appoints Cortney Wells as Director of Finance CI
Hydromer, Inc. Announces That New Facility in North Carolina Is Fully Operational with Extensive New Capabilities CI
Hydromer Inc. Announces the Addition of A New Global Business Development Manager to Propel Growth CI
Hydromer Selected as Key Coatings Provider for Avinger’s Image-Guided PAD Therapeutic Devices CI
Hydromer Inc Signs Agreement to Sell Their Hand and Surface Sanitizer Lines, Hydromer First Responder, HydroProtect and EscenciaProtect on the Stockd e-Commerce Marketplace CI
Hydromer as the Exclusive Coatings Partner for N8 Announces the CeraShield Coating Has Demonstrated the Ability to Inhibit and Reduce the Growth of Covid-19 Virus on Tube Surfaces CI
Hydromer Accelerates Its First Responder Sanitizer Production to Meet Growing Demand CI
Hydromer, Inc. and N8 Medical Partner to Bring Life-Saving Coated ET Tubes for COVID-19 Patients CI
More news
Managers TitleAgeSince
Chief Executive Officer - 23-01-08
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 39 23-08-06
Chairman - 23-08-06
Chief Executive Officer - 23-01-08
More insiders
Hydromer, Inc. is a provider of hydrophilic, thromboresistant, and antimicrobial coating technologies for medical devices. The Company is engaged in providing business-to- business (B2B) surface modification and coating solutions provider. The Company offers polymer research and development, and manufacturing services capabilities for a variety of applications. Its customers are located across North and South America, Europe, the Middle East, and Asia-Pacific. Its segments include Medical and Industrial. Medical segment provides medical coatings support to specialized FDA approved medical devices and medical coatings that reduce insertion and withdrawal friction and potential trauma and enhance the performance of medical devices used in anatomies of the human body. The Industrial segment provides customized anti-fog, anti-frost, and condensation-control coating solutions for a variety of applications on many substrates including polycarbonate, glass, metal, and polyurethane.
More about the company